Literature DB >> 9166291

Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart.

V Robert1, S Besse, A Sabri, J S Silvestre, P Assayag, V T Nguyen, B Swynghedauw, C Delcayre.   

Abstract

We compared two models of cardiac fibrosis in which collagen synthesis is controlled at different levels. Regulation is pretranslational in aldosterone-salt-induced hypertension in young rats and posttranslational in 24-month-old rats. However, little is known about the role of matrix metalloproteinases (MMP) in fibrosis development. Ventricular MMP activities were studied by zymography, and MMP-2 and MMP-1 mRNA levels were determined using slot-blot and ribonuclease protection assay, respectively. After 1 month of aldosterone-salt treatment, proMMP-2, MMP-2, and proMMP-1 collagenolytic activities and their gene expression were unchanged compared with sham-operated rats. After 2 months, total MMP-2 activity was increased by 40% with parallel stimulation of its gene expression. These changes were localized by in situ zymography within the media of coronary vessels. These results suggest that MMP play a prominent role in vascular remodeling during the first steps of hypertension. During aging, however, there were 40% and 45% decreases in MMP-2 and proMMP-1 activity, respectively, with a corresponding down-regulation of MMP-2 mRNA. These observations suggest that depression of the degradative pathway is partly responsible for age-associated fibrosis. Thus, MMP have differing involvements in the cardiac remodeling associated with hypertension or aging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166291

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  29 in total

1.  Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form.

Authors:  V I Kapelko
Journal:  Exp Clin Cardiol       Date:  2001

2.  Aging and Cardiac Fibrosis.

Authors:  Anna Biernacka; Nikolaos G Frangogiannis
Journal:  Aging Dis       Date:  2011-04       Impact factor: 6.745

3.  Recovery from volumetric muscle loss injury: A comparison between young and aged rats.

Authors:  John T Kim; Benjamin M Kasukonis; Lemuel A Brown; Tyrone A Washington; Jeffrey C Wolchok
Journal:  Exp Gerontol       Date:  2016-07-17       Impact factor: 4.032

4.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

Review 5.  Age associated communication between cells and matrix: a potential impact on stem cell-based tissue regeneration strategies.

Authors:  Kevin Lynch; Ming Pei
Journal:  Organogenesis       Date:  2014       Impact factor: 2.500

6.  Mechanoregulation of Myofibroblast Fate and Cardiac Fibrosis.

Authors:  Peter Kim; Nick Chu; Jennifer Davis; Deok-Ho Kim
Journal:  Adv Biosyst       Date:  2017-12-04

7.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

Review 8.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

9.  Urinary levels of matrix metalloproteinases and their tissue inhibitors in nephrotic children.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

10.  Structural remodelling of the sinoatrial node in obese old rats.

Authors:  J Yanni; J O Tellez; P V Sutyagin; M R Boyett; H Dobrzynski
Journal:  J Mol Cell Cardiol       Date:  2009-09-01       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.